Update 4/28/2020: QuVa Pharma, Inc., is now also voluntarily recalling all lots of its RECK 50 mL in Sodium Chloride-60 mL BD syringe, due to the recalled lots of Fresenius Kabi's ketorolac being used in the mixture. RECK is a combination of ropivacaine, epinephrine, clonidine and ketorolac.
The FDA announced Fresenius Kabi USA is voluntarily recalling 13 lots of ketorolac tromethamine injection USP due to the presence of particulate matter.